Could an arthritis drug boost chemo for tough breast cancers?
Disease control
Recruiting now
This study tests whether adding the arthritis drug tocilizumab to standard chemotherapy helps shrink tumors or delay cancer growth in people with metastatic triple-negative or ER-low breast cancer. The trial includes both Black and non-Black participants to see if the drug works …
Phase: PHASE2 • Sponsor: Kathy Miller • Aim: Disease control
Last updated May 17, 2026 10:04 UTC